Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior

Molecular Brain Research

Volumn 121, Issue 1-2, 2004, Pages 28-36

  Chourbaji, Sabine ^a   Hellweg, Rainer ^b   Brandis, Dorothee ^a   Zörner, Björn ^a   Zacher, Christiane ^a   Lang, Undine E ^b   Henn, Fritz A ^a   Hörtnagl, Heide ^c   Gass, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

BDNF; Behavior; Depression; HPA system; Mice; Monoamines; Neurotrophins

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN MONOAMINE; CHOLINE ACETYLTRANSFERASE; CORTICOSTERONE; CORTICOTROPIN; DOPAMINE; NORADRENALIN; SEROTONIN;

ADULTHOOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BIODEGRADATION; BRAIN LEVEL; BRAIN REGION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DEPRESSION; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; EMOTION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REPRESSION; EXPLORATORY BEHAVIOR; FEAR; FEMALE; FOREBRAIN; FRONTAL CORTEX; GENE DISRUPTION; HETEROZYGOTE; HIPPOCAMPUS; HORMONE DETERMINATION; HYPOTHALAMUS; IMMOBILIZATION STRESS; LEARNING; LOCOMOTION; MALE; MOUSE; MOUSE MUTANT; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; SYMPTOM; WILD TYPE;

EID: 1242306277     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2003.11.002     Document Type: Article

References (65)

1. Altar C.A. Neurotrophins and depression. Trends Pharmacol. Sci. 20:1999;59-61.
2. Barden N., Reul J.M., Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci. 18:1995;6-11.
3. Brown A.S., Gershon S. Dopamine and depression. J. Neural Transm. Gen. Sect. 91:1993;75-109.
4. Bunney W.E. Jr., Davis J.M. Norepinephrine in depressive reactions. A review. Arch. Gen. Psychiatry. 13:1965;483-494.
5. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry. 50:2001;260-265.
6. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 23:2002;238-245.
7. Duan W., Guo Z., Jiang H., Ware M., Mattson M.P. Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology. 144:2003;2446-2453.
8. Duman R.S., Vaidya V.A. Molecular and cellular actions of chronic electroconvulsive seizures. J. ECT. 14:1998;181-193.
9. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry. 54:1997;597-606.
10. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annu. Rev. Psychol. 48:1997;649-684.
11. Felice L.J., Felice J.D., Kissinger P.T. Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J. Neurochem. 31:1978;1461-1465.
12. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24:1975;407-409.
13. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego, CA.
14. Gass P., Wolfer D.P., Balschun D., Rudolph D., Frey U., Lipp H.P., Schutz G. Deficits in memory tasks of mice with CREB mutations depend on gene dosage. Learn. Mem. 5:1998;274-288.
15. Ghosh A., Carnahan J., Greenberg M.E. Requirement for BDNF in activity-dependent survival of cortical neurons. Science. 263:1994;1618-1623.
16. Hellweg R., Hock C., Hartung H.D. An improved and rapid highly sensitive enzyme immunoassay for nerve growth factor, technique. J. Methods Cell Mol. Biol. 1:1989;43-48.
17. Hellweg R., Nitsch R., Hock C., Jaksch M., Hoyer S. Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism. J. Neurosci. Res. 31:1992;479-486.
18. Hellweg R., Gericke C.A., Jendroska K., Hartung H.D., Cervos-Navarro J. NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease. Int. J. Dev. Neurosci. 16:1998;787-794.
19. Hellweg R., von Arming C.A.F., Büchner M., Huber R., Riepe M.W. Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation. Exp. Neurol. 183:2003;346-354.
20. Hensler J.G., Ladenheim E.E., Lyons W.E. Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF (+/-) mice. J. Neurochem. 85:2003;1139-1147.
21. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 23:2000;477-501.
22. Kernie S.G., Liebl D.J., Parada L.F. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 19:2000;1290-1300.
23. Knipper M., da Penha Berzaghi M., Blochl A., Breer H., Thoenen H., Lindholm D. Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus. Eur. J. Neurosci. 6:1994;668-671.
24. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8856-8860.
25. Kuehner C. Gender differences in unipolar depression: an update of epidemiological findings and possible explanations. Acta Psychiatr. Scand. 108:2003;163-174.
26. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
27. Linnarsson S., Bjorklund A., Ernfors P. Learning deficit in BDNF mutant mice. Eur. J. Neurosci. 9:1997;2581-2587.
28. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., Wihler C., Koliatsos V.E., Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. U. S. A. 96:1999;15239-15244.
29. MacQueen G.M., Ramakrishnan K., Croll S.D., Siuciak J.A., Yu G., Young L.T., Fahnestock M. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav. Neurosci. 115:2001;1145-1153.
30. Mamounas L.A., Blue M.E., Siuciak J.A., Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15:1995;7929-7939.
31. Manji H.K., Moore G.J., Chen G. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br. J. Psychiatry, Suppl. 41:2001;s107-s119.
32. Manji H.K., Quiroz J.A., Sporn J., Payne J.L., Denicoff K., Gray N.A., Zarate C.A. Jr., Charney D.S. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry. 53:2003;707-742.
33. McAllister A.K. Subplate neurons: a missing link among neurotrophins, activity, and ocular dominance plasticity? Proc. Natl. Acad. Sci. U. S. A. 96:1999;13600-13602.
34. McIlwain K.L., Merriweather M.Y., Yuva-Paylor L.A., Paylor R. The use of behavioral test batteries: effects of training history. Physiol. Behav. 73:2001;705-717.
35. Minichiello L., Korte M., Wolfer D., Kuhn R., Unsicker K., Cestari V., Rossi-Arnaud C., Lipp H.P., Bonhoeffer T., Klein R. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron. 24:1999;401-414.
36. Misslin R., Herzog F., Koch B., Ropartz P. Effects of isolation, handling and novelty on the pituitary-adrenal response in the mouse. Psychoneuroendocrinology. 7:1982;217-221.
37. Nagy T.R., Krzywanski D., Li J., Meleth S., Desmond R. Effect of group vs. single housing on phenotypic variance in C57BL/6J mice. Obes. Res. 10:2002;412-415.
38. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiatry. 1:1996;336-342.
39. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron. 34:2002;13-25.
40. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15:1995;7539-7547.
41. Olsson I.A., Dahlborn K. Improving housing conditions for laboratory mice: a review of "environmental enrichment" Lab. Anim. 36:2002;243-270.
42. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2:2001;24-32.
43. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:1977;730-732.
44. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., Lechan R.M., Jaenisch R. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15:2001;1748-1757.
45. Rogan M.T., LeDoux J.E. Emotion: systems, cells, synaptic plasticity. Cell. 85:1996;469-475.
46. Russo-Neustadt A., Ha T., Ramirez R., Kesslak J.P. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav. Brain Res. 120:2001;87-95.
47. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., Agerman K., Haapasalo A., Nawa H., Aloyz R., Ernfors P., Castren E. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 23:2003;349-357.
48. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry. 122:1965;509-522.
49. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22:2002;3251-3261.
50. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56:1997;131-137.
51. Smith M.A., Makino S., Kim S.Y., Kvetnansky R. Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology. 136:1995;3743-3750.
52. Smith M.A., Makino S., Kvetnansky R., Post R.M. Effects of stress on neurotrophic factor expression in the rat brain. Ann. N.Y. Acad. Sci. 771:1995;234-239.
53. Sperk G. Simultaneous determination of serotonin, 5-hydroxyindoleacetic acid, 3,4-dihydroxyphenylacetic acid and homovanillic acid by high performance liquid chromatography with electrochemical detection. J. Neurochem. 38:1982;840-843.
54. Sperk G., Berger M., Hortnagl H., Hornykiewicz O. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat. Eur. J. Pharmacol. 74:1981;279-286.
55. Ueyama T., Kawai Y., Nemoto K., Sekimoto M., Tone S., Senba E. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci. Res. 28:1997;103-110.
56. Vaidya V.A., Duman R.S. Depression - emerging insights from neurobiology. Br. Med. Bull. 57:2001;61-79.
57. van Gaalen M.M., Steckler T. Behavioural analysis of four mouse strains in an anxiety test battery. Behav. Brain Res. 115:2000;95-106.
58. Wang W., Salvaterra P.M., Loera S., Chiu A.Y. Brain-derived neurotrophic factor spares choline acetyltransferase mRNA following axotomy of motor neurons in vivo. J. Neurosci. Res. 47:1997;134-143.
59. Ward N.L., Hagg T. BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo. Exp. Neurol. 162:2000;297-310.
60. Willner P. Animal models as simulations of depression. Trends Pharmacol. Sci. 12:1991;131-136.
61. Wong M.L., Licinio J. Research and treatment approaches to depression. Nat. Rev. Neurosci. 2:2001;343-351.
62. Xu H., Steven Richardson J., Li X.M. Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology. 28:2003;53-62.
63. Yamada K., Mizuno M., Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 70:2002;735-744.
64. Zetterstrom T.S., Pei Q., Grahame-Smith D.G. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Mol. Brain Res. 57:1998;106-110.
65. Zörner B., Wolfer D.P., Brandis D., Kretz O., Zacher C., Madani R., Grunwald I., Lipp H.P., Klein R., Henn F.A., Gass P. Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than depressive. Biol. Psychiatry. 54:2003;972-982.